Loading clinical trials...
Loading clinical trials...
Phase 2 Single-Arm Study of Nanoliposomal Irinotecan With Fluorouracil and Leucovorin in Refractory Advanced High Grade Neuroendocrine Cancer of GI, Unknown or Pancreatic Origin
Conditions
Interventions
Fluorouracil
Leucovorin
+2 more
Locations
2
United States
Roswell Park Cancer Institute
Buffalo, New York, United States
Stony Brook Cancer Center
Stony Brook, New York, United States
Start Date
June 17, 2019
Primary Completion Date
October 18, 2022
Completion Date
August 26, 2024
Last Updated
January 30, 2025
Lead Sponsor
Roswell Park Cancer Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions